Sentiment Heatmap — Week of September 14, 2026
AlphAI classified 11,520 ticker level sentiment reads across 9,059 news articles the week of September 14, 2026. Net tone came in at 30.1% bullish, the weakest reading since the week of July 27 and the first break of the 35.0 to 36.5 percent band that had held for six straight weeks. Monday and Tuesday carried the whole move, at plus 14.1 and plus 27.3 against plus 38 to plus 40 from Thursday on. Volume turned back up for the first time since August 24, 11,520 reads against 9,901, though the level is still well under the August peak.
News tone in the week of September 14 ran net 30.1% bullish across 11,520 scored ticker reads, breaking a six week band of 35.0 to 36.5 percent. The damage was all in the first three days, when a coordinated call from AI chief executives to slow development met the first Federal Reserve rate hike since 2023. All twelve sectors still finished positive.
Healthcare led on breadth this time, and the top two industrial rows are one missile program rather than two companies
All twelve sectors finished net positive for a second consecutive week. Healthcare led at plus 47% on 1,267 reads splitting 815 bullish to 215 bearish, and the composition matters: in the previous issue one failed trial carried a third of the sector's bearish reads, while this week the sector was broad. AstraZeneca finished at plus 41, Eli Lilly plus 32, GSK plus 24, Ultragenyx plus 20, Novo Nordisk plus 15, AbbVie plus 14, Johnson & Johnson plus 13 and Medtronic plus 11. The events behind them were separate: FDA approval of Lilly's Inluriyo with Verzenio for ESR1 mutated advanced breast cancer, an EU recommendation for AstraZeneca's Enhertu plus a positive Phase III COPD readout, GSK's deal worth up to $750 million for Chimagen's trispecific T cell engager, and FDA approval of Ultragenyx's FAYUVI gene therapy. AstraZeneca also carried the week's clearest two sided story, since the SERENA-4 miss for camizestrant landed in the same window as the Enhertu recommendation.
Lockheed Martin posted the highest net of any company, 113 reads at 105 bullish to 2 bearish. That is order flow rather than a conviction trade, and it should be read that way: a Department of War framework agreement to scale AIM-260 JATM production, a $1.2 billion Army contract for the PrSM Increment 2 system, the proposed F-35 sale to Saudi Arabia, and GM Defense's first delivery of PAC-3 interceptor components. That last item is also why General Motors sits at plus 51, so two of the six most bullish rows on the board are the same missile program seen from two balance sheets. GM's own coverage was split, with the defense work on one side and a weak session for the whole auto complex on the other.
Generac was the only name on the board with no bearish read at all, 63 bullish to 0, on a $2.4 billion Amazon generator supply agreement that came with a $340 million equity stake in the company. It was checked for syndication before publication, because a marketing wire repeated across lookalike domains can manufacture an entry: 63 distinct headlines across 33 distinct domains, which is real coverage. Intel at plus 65 ran on eight customers evaluating its 14A process, a reported $20 billion fundraising and revived Ohio memory investment talks, against its chief executive's statement that Intel CPU supply can meet only half of current demand. Salesforce at plus 51 came almost entirely from a $63 billion revenue target for fiscal 2030. Zcash at plus 50 was a privacy coin rally above $1,400 with Grayscale's Zcash ETF closing in on $1 billion.
Concentration stayed low. The most covered name of the week was Bitcoin at 2.41% of all ticker reads, ahead of Nvidia at 1.77% and Intel at 1.42%, so no single subject dominates this board.
| Ticker | Company | Bull / bear reads | Net |
|---|---|---|---|
| LMT | Lockheed Martin | 105 / 2 | +103 |
| INTC | Intel | 103 / 38 | +65 |
| GNRC | Generac Holdings | 63 / 0 | +63 |
| NVDA | Nvidia | 118 / 59 | +59 |
| AAPL | Apple | 76 / 20 | +56 |
| GM | General Motors | 57 / 6 | +51 |
| CRM | Salesforce | 56 / 5 | +51 |
| ZEC-USD | Zcash | 52 / 2 | +50 |
| AZN | AstraZeneca | 52 / 11 | +41 |
| GOOGL | Alphabet | 48 / 9 | +39 |
| LCID | Lucid Group | 39 / 2 | +37 |
| CRWD | CrowdStrike | 44 / 8 | +36 |
The whole decline was priced in the first three days, and the bearish engine was financing rather than trading
The week did not weaken gradually. Monday September 14 came in at plus 14.1 on 2,089 reads, Tuesday at plus 27.3 and Wednesday at plus 24.4, then Thursday printed plus 40.5, Friday plus 38.2 and the weekend plus 37.7 and plus 37.8. Two clusters explain the front of the week. A coordinated call from AI chief executives including Dario Amodei, Sam Altman and Elon Musk to slow frontier development ran through 46 articles for 139 ticker reads, 94 of them bearish, and took the chip complex with it, with SoftBank down 13%. The Federal Reserve then delivered its first rate hike since 2023, which 170 articles touched for 418 reads. Technology held its volume across the window, 3,193 reads against 3,029 a week earlier, and lost 21 points of tone, from plus 53 to plus 32. The resulting 30.1% net is the weakest reading since the week of July 27 and the first one outside 35.0 to 36.5 in six weeks.
The bearish side of the board has a common thread, and it is the balance sheet rather than the business. Oracle was the third most bullish name in the previous issue at plus 107, and it is at minus 34 here, on $18 billion of data-center loans trading at 89 to 91 cents and a restructuring charge $700 million larger than planned. CoreWeave at minus 15 priced an upsized $3.7 billion convertible offering, and Axon at minus 24 priced $1 billion of zero coupon convertible notes; in both cases the financing itself was what read negative, while the operating news in the same window was fine. Fluence Energy was the worst reading of the week, 45 reads at 1 bullish to 43 bearish, after cutting full year guidance on US supply chain problems and delays at its Houston projects. In a week that opened with a rate hike, the bearish reads concentrated on how companies are funding capital spending rather than on what they are selling.
The rest of the bearish list is company specific. J.B. Hunt read 1 bullish to 28 bearish after warning on third quarter profit, with the stock down 13%. Lennar read 1 to 25 after third quarter earnings fell and it cut its annual delivery target, which is the same week our Insider Radar reported Berkshire Hathaway's first ever Form 4 on the company, so the tape and the filings pointed opposite ways on one name. Abbott read 4 to 30 on a $385 million settlement of infant formula claims. Bank of America read 4 to 24 on fee guidance implying a 10% to 20% drop. Regulation was again the only negative news category of the week at minus 9% over 1,049 reads, against technology at plus 70% over 1,644 reads and mergers and acquisitions at plus 57% over 848. Inside regulation sit the Senate rejecting the CLARITY Act by 50 to 49, which moved the crypto equities, proposed pharmaceutical tariffs, the Justice Department beef price probe widening to eight grocery retailers, and PFAS litigation.
One number is worth stating plainly. Volume turned back up: 11,520 reads across 9,059 articles is 16% above the prior week's 9,901 and the first weekly increase since August 24. The level is still 28% under the August 3 peak of 16,072 reads, so this is a break in the slide rather than a recovery of it. Both of the things that made the previous issue stable therefore gave way in one week. The tone band that had held for six weeks broke, and the run of falling volume stopped.
| Ticker | Company | Bull / bear reads | Net |
|---|---|---|---|
| FLNC | Fluence Energy | 1 / 43 | -42 |
| ORCL | Oracle | 32 / 66 | -34 |
| JBHT | J.B. Hunt Transport Services | 1 / 28 | -27 |
| ABT | Abbott Laboratories | 4 / 30 | -26 |
| AXON | Axon Enterprise | 6 / 30 | -24 |
| LEN | Lennar | 1 / 25 | -24 |
| BAC | Bank of America | 4 / 24 | -20 |
| ENVA | Enova International | 1 / 20 | -19 |
| AAL | American Airlines Group | 5 / 21 | -16 |
| NKE | Nike | 6 / 22 | -16 |
| PLAY | Dave & Buster's Entertainment | 0 / 15 | -15 |
| CRWV | CoreWeave | 32 / 47 | -15 |
Methodology
Covers every enriched news article published between September 14 and September 20, 2026 that AlphAI scored at relevance 6 or higher, the same floor used for the per-stock sentiment strips on the site, excluding SEC Form 4 insider filings, whose templated text is almost always neutral. The remaining sample is 10,959 reads from general news, 543 from SEC 8-K filings and 18 from SEC 6-K filings. For each article, AlphAI assigns a sentiment of positive, neutral or negative to every company it identifies, and only tickers that pass enricher validation are counted. A 'ticker read' is one such per-ticker label, so an article naming six companies contributes up to six reads, and a market-wide or sector-wide story is counted once for every ticker it tags; the largest multi-ticker article in this window is a market wrap ahead of the Fed decision that tags 22 tickers. Net tone is bullish reads minus bearish reads as a share of all reads for that group. Sectors come from each company's classification, which 98.7% of reads carry, and a sector needs at least 15 reads in the window to appear on the chart. The two ticker leaderboards rank strictly by net reads, bullish minus bearish, among names with at least 4 reads, so a name absent from them scored below the ones shown. Share classes and secondary venues are ranked separately, and this week that choice is visible: Alphabet's two classes combine to net +45 (GOOGL +39, GOOG +6), which would place the combined entry above AstraZeneca instead of below it, though it changes no name on the board. No other company had a second class or venue above the 4-read floor, and the foreign lines of names on the boards (AstraZeneca, TotalEnergies, Nokia, Oracle preferred) took zero reads in this window, so nothing else was affected. Two rows on the bullish board are one event and are described as such in the prose rather than counted as independent stories: Lockheed Martin and General Motors both rise partly on PAC-3 interceptor production, where GM Defense is the new component supplier. Lockheed Martin's reading is contract and order flow coverage, not a judgement on valuation. Weekly volume moves with both the news cycle and our collector coverage, and this window ran 16% above the prior one while still sitting 28% under the August 3 peak, so compare percentages across issues, and treat raw volumes as a separate series. This is a filtered readout of public news coverage, not investment advice or a measure of price performance.
Sources: AlphAI enriched news feed, GDELT Project (global news index), SEC EDGAR Form 8-K filings
Get this data live
These figures come straight from the AlphAI feed. Pull scored SEC Form 4 filings and financial news programmatically via the API and MCP server, or set a free alert on any ticker.